City
Epaper

Stock indices open in negative territory with mixed global cues

By ANI | Updated: April 2, 2024 09:50 IST

Mumbai (Maharashtra) [India], April 2 : Indian benchmark indices, Sensex-Nifty began trading on a cautious note in the red ...

Open in App

Mumbai (Maharashtra) [India], April 2 : Indian benchmark indices, Sensex-Nifty began trading on a cautious note in the red territory, influenced by mixed signals from global markets on Tuesday.

The Sensex, India's key equity index, opened down by 131.51 points, or 0.18 per cent, at 73,883.04, while the Nifty, another major index, started the session lower by 23.25 points, or 0.1 per cent, at 22,438.75.

Analysis of the Nifty companies showed a mixed picture, with 25 advancing and 24 declining. Among the notable gainers among Nifty firms were Adani Ports, BPCL, Bajaj Auto, ONGC, and IndusInd Bank.

Conversely, ICICI Bank, TCS, Cipla, Sun Pharma, and Wipro were among the top losers in the initial trading hours.

Varun Aggarwal, founder and managing director Profit Idea, said, "The previous trading session witnessed domestic equity benchmarks ending on a positive note, with the Nifty 50 surpassing the 22,400 level. The Sensex closed higher by 363.20 points at 74,014.55, while the Nifty 50 settled up by 135.10 points, or 0.61 per cent, at 22,462.00. Technically, the Nifty 50 formed a small positive candle, suggesting a potential consolidation or minor dip after reaching new highs."

He added, "Despite the cautious start, the broader trend of the Nifty remains positive, with the market eyeing crucial overhead resistance levels of 22,500 - 22,550."

Market analysts indicate that any potential consolidation could offer buying opportunities, with expectations of an upside breakout toward the 22,800 levels.

An analysis of Nifty Open Interest data reveals significant interest at the 22,500 strike prices on the call side and at 22,200 on the put side, indicating potential levels of support and resistance for the index.

In Asian markets, Australian and Japanese equities showed minimal changes, while Hong Kong markets reopened after a holiday break.

In the United States, equity futures edged lower following a mixed session on Wall Street. Bond markets reflected increased yields following unexpected manufacturing expansion in the US, with Treasury yields climbing over 10 basis points.

Investor attention remains focused on the Federal Reserve's stance on monetary policy, with expectations of potential rate cuts later in the year.

Additionally, market participants await key data releases, including employment figures and meeting minutes from the Reserve Bank of Australia.

Commodities like oil and gold continue to be influenced by geopolitical factors and supply dynamics, adding further complexity to market movements.

As the trading session progresses, investors will closely monitor global cues and domestic developments for further insights into market direction and sentiment.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalEAM Jaishankar meets FMs of South Africa, Mexico, Saskatchewan Premier on sidelines of G7 Foreign Ministers' Meet

NationalECI's decision to relax BLA appointment norms irks Trinamool, BJP welcomes move

Cricket"Great X-factor that they possess": England skipper hails Archer and Wood's pace ahead of Ashes 2025

BusinessIIM Udaipur Hosts 'Startup Showcase & Pitch Day' Organized by IIM Udaipur Incubation Centre and Saksham - The Entrepreneurship Cell

TechnologyMoney supply rises for 6th straight month amid strong stock market: BOK

Business Realted Stories

BusinessMoney supply rises for 6th straight month amid strong stock market: BOK

BusinessVisa's Scan to Pay Goes Live, Bringing Seamless QR Payments to Millions of Merchants in Asia Pacific

BusinessGroww Share Price: Billionbrains Garage Ventures Stock Listed at 12% Premium

BusinessPC Jeweller Posts Strong Q2FY26 Profit and Revenue Growth, Accelerates Debt Reduction and Regains Full Inventory Control

BusinessBalaxi Pharmaceuticals Announces FY25 Turnaround and Path to Accelerated Growth